Press release
Insights on the TB Disease Vaccine Market Report & Forecast to 2028 - by Players, Types, Applications and Region
QY Research latest released a report about TB Disease Vaccine. This report focuses on global and United States TB Disease Vaccine, also covers the segmentation data of other regions in regional level and county level.Key Market Segmentation
TB Disease Vaccine is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global TB Disease Vaccine will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the TB Disease Vaccine size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
For more information about this report, visit
https://us.qyresearch.com/reports/355752/tb-disease-vaccine
Breakup by Type
Prevention Vaccines
Post-exposure Vaccines
Others
Breakup by Application
Self-Procurement
UNICEF
Others
Breakup by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Breakup by Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Key Questions Answered in This Report
How has the Global and United States TB Disease Vaccine performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the TB Disease Vaccine type?
What is the breakup of the market based on the application?
What is the breakup of the market size based on the region?
What is the breakup of the market based on the region Level & country Level?
What is the structure of the Global and United States TB Disease Vaccine and who are the key players?
Key Topics Covered:
1 Study Coverage
1.1 TB Disease Vaccine Product Introduction
1.2 Global TB Disease Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global TB Disease Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global TB Disease Vaccine Sales in Volume for the Year 2017-2028
1.3 United States TB Disease Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States TB Disease Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States TB Disease Vaccine Sales in Volume for the Year 2017-2028
1.4 TB Disease Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States TB Disease Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of TB Disease Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 TB Disease Vaccine Market Dynamics
1.5.1 TB Disease Vaccine Industry Trends
1.5.2 TB Disease Vaccine Market Drivers
1.5.3 TB Disease Vaccine Market Challenges
1.5.4 TB Disease Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 TB Disease Vaccine Market Segment by Type
2.1.1 Prevention Vaccines
2.1.2 Post-exposure Vaccines
2.1.3 Others
2.2 Global TB Disease Vaccine Market Size by Type
2.2.1 Global TB Disease Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global TB Disease Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global TB Disease Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States TB Disease Vaccine Market Size by Type
2.3.1 United States TB Disease Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States TB Disease Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States TB Disease Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 TB Disease Vaccine Market Segment by Application
3.1.1 Self-Procurement
3.1.2 UNICEF
3.1.3 Others
3.2 Global TB Disease Vaccine Market Size by Application
3.2.1 Global TB Disease Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global TB Disease Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global TB Disease Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States TB Disease Vaccine Market Size by Application
3.3.1 United States TB Disease Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States TB Disease Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States TB Disease Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global TB Disease Vaccine Competitor Landscape by Company
4.1 Global TB Disease Vaccine Market Size by Company
4.1.1 Top Global TB Disease Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global TB Disease Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global TB Disease Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global TB Disease Vaccine Price by Manufacturer (2017-2022)
4.2 Global TB Disease Vaccine Concentration Ratio (CR)
4.2.1 TB Disease Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of TB Disease Vaccine in 2021
4.2.3 Global TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global TB Disease Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global TB Disease Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers TB Disease Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into TB Disease Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States TB Disease Vaccine Market Size by Company
4.5.1 Top TB Disease Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States TB Disease Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States TB Disease Vaccine Sales by Players (2020, 2021 & 2022)
5 Global TB Disease Vaccine Market Size by Region
5.1 Global TB Disease Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global TB Disease Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global TB Disease Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global TB Disease Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global TB Disease Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global TB Disease Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global TB Disease Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America TB Disease Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America TB Disease Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific TB Disease Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific TB Disease Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe TB Disease Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe TB Disease Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America TB Disease Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America TB Disease Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa TB Disease Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa TB Disease Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Merck
7.1.1 Merck Corporation Information
7.1.2 Merck Description and Business Overview
7.1.3 Merck TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck TB Disease Vaccine Products Offered
7.1.5 Merck Recent Development
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Corporation Information
7.2.2 Japan BCG Lab Description and Business Overview
7.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Japan BCG Lab TB Disease Vaccine Products Offered
7.2.5 Japan BCG Lab Recent Development
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporation Information
7.3.2 Serum Institute of India Description and Business Overview
7.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Serum Institute of India TB Disease Vaccine Products Offered
7.3.5 Serum Institute of India Recent Development
7.4 AJ Vaccines
7.4.1 AJ Vaccines Corporation Information
7.4.2 AJ Vaccines Description and Business Overview
7.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 AJ Vaccines TB Disease Vaccine Products Offered
7.4.5 AJ Vaccines Recent Development
7.5 BioFarma
7.5.1 BioFarma Corporation Information
7.5.2 BioFarma Description and Business Overview
7.5.3 BioFarma TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 BioFarma TB Disease Vaccine Products Offered
7.5.5 BioFarma Recent Development
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Corporation Information
7.6.2 GreenSignal Bio Pharma Description and Business Overview
7.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GreenSignal Bio Pharma TB Disease Vaccine Products Offered
7.6.5 GreenSignal Bio Pharma Recent Development
7.7 China National Biotec
7.7.1 China National Biotec Corporation Information
7.7.2 China National Biotec Description and Business Overview
7.7.3 China National Biotec TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 China National Biotec TB Disease Vaccine Products Offered
7.7.5 China National Biotec Recent Development
7.8 Biomed Lublin
7.8.1 Biomed Lublin Corporation Information
7.8.2 Biomed Lublin Description and Business Overview
7.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Biomed Lublin TB Disease Vaccine Products Offered
7.8.5 Biomed Lublin Recent Development
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Corporation Information
7.9.2 Taj Pharmaceuticals Description and Business Overview
7.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Taj Pharmaceuticals TB Disease Vaccine Products Offered
7.9.5 Taj Pharmaceuticals Recent Development
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Corporation Information
7.10.2 Ataulpho de Paiva Description and Business Overview
7.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Ataulpho de Paiva TB Disease Vaccine Products Offered
7.10.5 Ataulpho de Paiva Recent Development
7.11 IVAC
7.11.1 IVAC Corporation Information
7.11.2 IVAC Description and Business Overview
7.11.3 IVAC TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.11.4 IVAC TB Disease Vaccine Products Offered
7.11.5 IVAC Recent Development
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Corporation Information
7.12.2 Queen Saovabha Mem. Inst Description and Business Overview
7.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Queen Saovabha Mem. Inst Products Offered
7.12.5 Queen Saovabha Mem. Inst Recent Development
7.13 Microgen
7.13.1 Microgen Corporation Information
7.13.2 Microgen Description and Business Overview
7.13.3 Microgen TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Microgen Products Offered
7.13.5 Microgen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 TB Disease Vaccine Industry Chain Analysis
8.2 TB Disease Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 TB Disease Vaccine Distributors
8.3 TB Disease Vaccine Production Mode & Process
8.4 TB Disease Vaccine Sales and Marketing
8.4.1 TB Disease Vaccine Sales Channels
8.4.2 TB Disease Vaccine Distributors
8.5 TB Disease Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Receive Free Sample, Charts, Tables or Full Report, Please enter:
https://us.qyresearch.com/reports/355752/tb-disease-vaccine
Any questions or requirements, please do not hesitate to contact us.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QY Research latest released a report about TB Disease Vaccine. This report focuses on global and United States TB Disease Vaccine, also covers the segmentation data of other regions in regional level and county level.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the TB Disease Vaccine Market Report & Forecast to 2028 - by Players, Types, Applications and Region here
News-ID: 2635232 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
